Pediatric Allergic Rhinitis: When Meds Fall Short

Prospective cohort compares surgical vs medical management in refractory pediatric disease.

By
Kathryn Wighton
April 9, 2026
3 min

Conexiant

Overview

Inferior turbinate reduction significantly improves sinonasal symptoms and quality of life in pediatric patients with refractory allergic rhinitis compared to continued medical therapy. The study demonstrated higher rates of endoscopic disease regression and reduced dependence on medications post-surgery.

Background

Pediatric allergic rhinitis is a common condition that can significantly impact a child's quality of life. While intranasal corticosteroids and antihistamines are standard treatments, some patients remain symptomatic despite these therapies. Understanding alternative interventions, such as inferior turbinate reduction, is crucial for managing refractory cases effectively.

Data Highlights

{'format': 'Ensure the table is properly formatted in the final document.'}

Key Findings

{'add': 'Include sample size and study design details.'}

Clinical Implications

{'add': 'Mention potential risks or complications associated with surgery.'}

Conclusion

Inferior turbinate reduction is a viable surgical option for improving sinonasal symptoms in children with refractory allergic rhinitis, demonstrating better outcomes than continued medical therapy.